SE8702389L - Mellanprodukter for framstellning av 1,4-disubstituerade piperazinderivat - Google Patents

Mellanprodukter for framstellning av 1,4-disubstituerade piperazinderivat

Info

Publication number
SE8702389L
SE8702389L SE8702389A SE8702389A SE8702389L SE 8702389 L SE8702389 L SE 8702389L SE 8702389 A SE8702389 A SE 8702389A SE 8702389 A SE8702389 A SE 8702389A SE 8702389 L SE8702389 L SE 8702389L
Authority
SE
Sweden
Prior art keywords
intermediates
preparation
piperazine derivatives
disubstituted piperazine
benzisothiazol
Prior art date
Application number
SE8702389A
Other languages
English (en)
Other versions
SE462162B (sv
SE8702389D0 (sv
Inventor
Jr D L Temple
J P Vevich
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8702389L publication Critical patent/SE8702389L/sv
Publication of SE8702389D0 publication Critical patent/SE8702389D0/sv
Publication of SE462162B publication Critical patent/SE462162B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE8702389A 1981-12-23 1987-06-09 Bensisotiazol- och bensisoxazol-piperazinderivat SE462162B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/333,830 US4411901A (en) 1981-12-23 1981-12-23 Benzisothiazole and benzisoxazole piperazine derivatives

Publications (3)

Publication Number Publication Date
SE8702389L true SE8702389L (sv) 1987-06-09
SE8702389D0 SE8702389D0 (sv) 1987-06-09
SE462162B SE462162B (sv) 1990-05-14

Family

ID=23304433

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8207350A SE453502B (sv) 1981-12-23 1982-12-22 Bensisotiazol- och bensisoxazol-piperazinderivat samt forfaranden for framstellning derav
SE8702389A SE462162B (sv) 1981-12-23 1987-06-09 Bensisotiazol- och bensisoxazol-piperazinderivat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE8207350A SE453502B (sv) 1981-12-23 1982-12-22 Bensisotiazol- och bensisoxazol-piperazinderivat samt forfaranden for framstellning derav

Country Status (26)

Country Link
US (1) US4411901A (sv)
JP (2) JPS58110576A (sv)
KR (1) KR870001022B1 (sv)
AU (1) AU550780B2 (sv)
BE (1) BE895469A (sv)
CA (1) CA1205806A (sv)
CH (2) CH656617A5 (sv)
CY (1) CY1376A (sv)
DE (1) DE3247530A1 (sv)
DK (2) DK160939C (sv)
ES (4) ES8401970A1 (sv)
FI (1) FI78697C (sv)
FR (2) FR2521561B1 (sv)
GB (1) GB2114119B (sv)
GR (1) GR77108B (sv)
HK (1) HK5088A (sv)
HU (2) HU195806B (sv)
IE (1) IE54789B1 (sv)
IT (1) IT1158037B (sv)
KE (1) KE3718A (sv)
LU (1) LU84550A1 (sv)
NL (1) NL8204910A (sv)
PT (1) PT76017B (sv)
SE (2) SE453502B (sv)
SG (1) SG30087G (sv)
ZA (1) ZA828544B (sv)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
US4656280A (en) * 1984-03-07 1987-04-07 E. I. Du Pont De Nemours And Company Radioiodinated dopamine receptor ligand
US4590196A (en) * 1984-08-23 1986-05-20 Bristol-Myers Company Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives
JPH0625181B2 (ja) * 1985-03-27 1994-04-06 住友製薬株式会社 新規なイミド誘導体
US4656173A (en) * 1985-04-24 1987-04-07 Bristol-Myers Company Antipsychotic benzisothiazole S-oxide compound
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
AU593194B2 (en) * 1986-09-26 1990-02-01 Sumitomo Pharmaceuticals Company, Limited Imide derivatives ,and their production and use
MX174210B (es) * 1987-02-17 1994-04-28 Pfizer Procedimiento para la preparacion de compuestos arilpiperazinil-alquilenfenil-p-heterociclicos
CA1335289C (en) * 1987-10-26 1995-04-18 Fujio Antoku Piperidinyl benzisoxazole derivatives, their production and pharmaceutical use
US4855430A (en) * 1987-11-12 1989-08-08 American Home Products Corporation Polycyclicamine with psychotropic activity
WO1989004311A1 (en) * 1987-11-12 1989-05-18 American Home Products Corporation Polycyclicamines with psychotropic activity
US5801186A (en) * 1987-11-20 1998-09-01 Hoechst Marion Roussel, Inc. 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds
ATE81123T1 (de) * 1987-11-20 1992-10-15 Hoechst Roussel Pharma 3-(4(1-substituierte-4-piperazinyl)butyl>-4thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel.
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
US5116970A (en) * 1988-02-18 1992-05-26 New James S Psychotropic heterobicycloalkylpiperazine derivatives: 2. fused pyridazinones
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
US5015740A (en) * 1988-08-05 1991-05-14 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
NZ230045A (en) * 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions
WO1990002552A1 (en) * 1988-09-16 1990-03-22 Pfizer Inc. Antipsychotic 4-[4-(3-benzisothiazolyl)-1-piperazinyl]butyl bridged bicyclic imides
US4847252A (en) * 1988-10-25 1989-07-11 Bristol-Myers Company Method for alleviation of vascular headache
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US4956368A (en) * 1989-07-24 1990-09-11 Bristol-Myers Company Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione
US4968792A (en) * 1989-09-25 1990-11-06 American Home Products Corporation Psychotropic benzisothiazole derivatives
FR2671350A1 (fr) * 1991-01-08 1992-07-10 Adir Nouveaux derives de benzisoxazole et de benzisothiazole, leur procede de preparation, et les compositions pharmaceutiques les renfermant.
US5098904A (en) * 1990-06-27 1992-03-24 Bristol-Myers Squibb Company Cerebral function enhancing pyrimidinyl derivatives
JP2800953B2 (ja) * 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体
US5266571A (en) * 1992-01-09 1993-11-30 Amer Moh Samir Treatment of hemorrhoids with 5-HT2 antagonists
GB9226857D0 (en) * 1992-12-23 1993-02-17 Boyd Edward A Pharmaceutical compositions
US5599815A (en) * 1993-02-04 1997-02-04 Meiji Seika Kabushiki Kaisha Antipsychotic benzoisothiazolyl piperazine derivatives
HUT69376A (en) * 1993-05-04 1995-09-28 Egyt Gyogyszervegyeszeti Gyar Process for preparing heterocyclic compounds
PL187404B1 (pl) 1995-02-28 2004-07-30 Lundbeck & Co As H Związki 4-aminotetrahydrobenzoizoksazolowe i-izotiazolowe oraz zawierające je kompozycje farmaceutyczne
WO1996039397A1 (en) * 1995-06-06 1996-12-12 Hoechst Marion Roussel, Inc. Benzisoxazole and indazole derivatives as antipsychotic agents
EP1757292A1 (en) 1997-09-05 2007-02-28 Pfizer Products Inc. Method of treating ocd and tic disorders
AU4062900A (en) * 1999-04-06 2000-10-23 Sepracor, Inc. Methods and compositions for the treatment of neuroleptic and related disorders using ziprasidone metabolites
US7030142B1 (en) 1999-04-06 2006-04-18 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using ziprasidone metabolites
EP1558608A1 (en) * 2002-10-28 2005-08-03 Warner-Lambert Company LLC Oxindole substituted piperazine derivatives
CA2505397A1 (en) * 2002-11-08 2004-05-21 Warner-Lambert Company Llc Phenylalkyl and pyridylalkyl piperazine derivatives
EP2578216A1 (en) 2006-11-22 2013-04-10 Seaside Therapeutics, Inc. Methods of treating fragile x syndrome
US8981095B2 (en) 2011-07-28 2015-03-17 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of lurasidone and salts thereof
CN105669665A (zh) * 2016-03-15 2016-06-15 烟台贝森医药科技有限公司 哌罗匹隆的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1595920B2 (de) * 1964-11-04 1978-08-10 Merck Patent Gmbh, 6100 Darmstadt 4-(co-Piperazinoalkyl)-pyrazole, ihre Salze und Verfahren zu ihrer Herstellung
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
DE1695410A1 (de) * 1967-04-20 1971-04-08 Merck Patent Gmbh Verfahren zur Herstellung von 1-(Thiazolyl-5-alkyl)-4-(pyridyl-2)-piperazinen
DE1670907B2 (de) * 1967-08-16 1976-07-22 Bayer Ag, 5090 Leverkusen N-disubstituierte 3-amino-1,2benzisothiazole und verfahren in ihrer herstellung
US3528989A (en) * 1967-11-14 1970-09-15 Colgate Palmolive Co 3-aminoalkyl derivatives of 2,1-benzisothiazoline
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
AR207986A1 (es) * 1974-07-01 1976-11-22 Sumitomo Chemical Co Un procedimiento para producir compuestos del 3-(aminoalquil n-sustituido)-benz-2,1-isoxazol
US3940398A (en) * 1975-01-23 1976-02-24 E. R. Squibb & Sons, Inc. 2-[[4-(Azine or diazine or triazine)-1-piperazinyl]alkyl]-1H-benz[de]isoquinoline-1,3(2H)-diones
DE2734866A1 (de) * 1977-08-03 1979-02-22 Basf Ag Neue 1,2-benzisothiazole und verfahren zu ihrer herstellung
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
AU521110B2 (en) * 1978-06-20 1982-03-18 Synthelabo Phenylpiperazine derivatives

Also Published As

Publication number Publication date
ES525471A0 (es) 1985-02-01
LU84550A1 (fr) 1983-09-08
HU195806B (en) 1988-07-28
JPS58110576A (ja) 1983-07-01
FI824379L (fi) 1983-06-24
FR2531431A1 (sv) 1984-02-10
FI824379A0 (fi) 1982-12-20
GR77108B (sv) 1984-09-06
SE8207350D0 (sv) 1982-12-22
DK566282A (da) 1983-06-24
DK307590D0 (da) 1990-12-28
CH659070A5 (de) 1986-12-31
FR2521561A1 (fr) 1983-08-19
IT1158037B (it) 1987-02-18
SE453502B (sv) 1988-02-08
BE895469A (fr) 1983-06-23
ZA828544B (en) 1983-09-28
KR870001022B1 (ko) 1987-05-23
GB2114119B (en) 1985-11-27
ES8503349A1 (es) 1985-02-01
DE3247530A1 (de) 1983-06-30
ES518168A0 (es) 1984-01-16
KE3718A (en) 1987-04-16
US4411901A (en) 1983-10-25
SE462162B (sv) 1990-05-14
ES8401970A1 (es) 1984-01-16
ES525470A0 (es) 1985-02-01
IE54789B1 (en) 1990-02-14
SG30087G (en) 1987-07-17
GB2114119A (en) 1983-08-17
IE823053L (en) 1983-06-23
IT8249709A0 (it) 1982-12-21
PT76017B (en) 1985-12-20
ES8503683A1 (es) 1985-04-01
DK160939B (da) 1991-05-06
DK162601B (da) 1991-11-18
SE8702389D0 (sv) 1987-06-09
FI78697C (sv) 1989-09-11
HU190997B (en) 1986-12-28
DK307590A (da) 1990-12-28
ES524946A0 (es) 1985-04-01
PT76017A (en) 1983-01-01
JPH0517457A (ja) 1993-01-26
CA1205806A (en) 1986-06-10
DK162601C (da) 1992-05-11
SE8207350L (sv) 1983-08-10
AU550780B2 (en) 1986-04-10
NL8204910A (nl) 1983-07-18
HK5088A (en) 1988-01-29
FR2521561B1 (fr) 1986-10-10
KR840002832A (ko) 1984-07-21
DK160939C (da) 1991-10-21
CY1376A (en) 1987-08-07
FR2531431B1 (sv) 1986-10-10
CH656617A5 (de) 1986-07-15
ES8502991A1 (es) 1985-02-01
FI78697B (fi) 1989-05-31
JPH0577669B2 (sv) 1993-10-27
AU9087282A (en) 1983-06-23

Similar Documents

Publication Publication Date Title
SE8702389D0 (sv) Mellanprodukter for framstellning av 1,4-disubstituerade piperazinderivat
NO924696D0 (no) Fremgangsmaate for fremstilling av oksazolidinon- og tiazolidinon-derivater
NZ237565A (en) Substituted thiazolidinones, oxazolidinones or imidazolidinones and antiinflammatory pharmaceutical compositions thereof
NO933093L (no) Monohydrat av 5-(2-(4-(1,2-benzisotiazol-3-yl)-1-piperazinyl)-etyl)-6-klor-1,3-dihydro-2H-indol-2-on hydroklorid
LU90711I2 (fr) 5-(4-/2-(N-m-thyl-n-(2-pyridyl)amino)-thoxy/benzyl)-2,4-thiazolidinedione ou ses sels et d-riv-s pharmaceutiquement acceptables en particulier son sel mal-ate ou ses solvates pharmaceutiquement acceptables
SE8106060L (sv) Kvaternera spiroammoniumhalider och forfarande for framstellning av n-(2-pyrimidinyl)piperazinylalkylazaspiroalkandioner
DE69006699T2 (de) Serotonin-Antagonisten, ihre Herstellung und sie enthaltende Arzneimittel.
SE8204550L (sv) Tiazolidinylalkylen-piperazin-derivat, forfarande for framstellning derav samt farmaceutiska preparat innehallande nemnda derivat
PE20020603A1 (es) Derivados de pirimidina como antagonista del receptor del neuropeptido y (npy)
SE8600173L (sv) Antipsykotiska cykliska imidderivat av 2-(4-butylpiperazin-1-yl)pyridiner s
SE8602061D0 (sv) Antipsychotic fused-ring pyridinylpiperazine derivatives
MY103788A (en) Benzothiazine dioxide derivatives
SE8601883L (sv) Bensisotiazol-s-oxid med antipsykotisk verkan
ATE60586T1 (de) Azolhalbaminal-derivate und ihre verwendung als nitrifikationsinhibitoren.
ES8401763A1 (es) Un procedimiento para la preparacion de derivados de espiroti-azolidinil-piperazina.
NO942668L (no) Alkylderivater av trazodon med CNS-aktivitet
NO167390C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-(2-pyrimidinyl)-1-piperazinyl heterocykliske carbonylderivater.
ES2061889T3 (es) Nuevos derivados de la 2-aminodecalina y su nucleo.
ATE108783T1 (de) 2-imino-6-polyfluoralkyl-3-heterocyclylalkyl- benzothiazolinderivate, ihre herstellung und sie enthaltende arzneimittel.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8702389-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8702389-1

Format of ref document f/p: F